27th Oct 2020 15:16
Sareum Holdings PLC - Cambridge-based specialist drug development company focused on cancer and autoimmune diseases - Says application for GBP174,000 grant approved by UK Research & Innovation to investigate SDC-1801 to treat severe Covid-19.
Current stock price: 2.32 pence
Year-to-date change: up sharply from 0.36p
By Eric Cunha; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Sareum